Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-000760-18Phase 4Terminated
Phase 4 trial of bupivacaine in bronchial carcinoma, sponsored by Prof. Peter Licht. Primary endpoint: Intensity of pain. Started Aug 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-000760-18.